Zooming in on the schedule of bone-modifying drugs

Lancet Oncol. 2013 Jun;14(7):575-6. doi: 10.1016/S1470-2045(13)70209-2. Epub 2013 May 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Breast Neoplasms / drug therapy*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid